vs

Side-by-side financial comparison of Arcellx, Inc. (ACLX) and INTELLIGENT PROTECTION MANAGEMENT CORP. (IPM). Click either name above to swap in a different company.

Arcellx, Inc. is the larger business by last-quarter revenue ($8.1M vs $6.1M, roughly 1.3× INTELLIGENT PROTECTION MANAGEMENT CORP.). On growth, INTELLIGENT PROTECTION MANAGEMENT CORP. posted the faster year-over-year revenue change (2091.6% vs -79.3%). Over the past eight quarters, INTELLIGENT PROTECTION MANAGEMENT CORP.'s revenue compounded faster (54.7% CAGR vs -24.6%).

Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.

Intelligent Limited is a Holding Company and Parent company headquartered in Gloucestershire, United Kingdom and was incorporated on 21 May 2008. Intelligent Limited provides a group management structure for four companies and was born out of the operations of International Intelligence Limited, a company specialising in Intelligence, Counter Espionage and TSCM sweeping.

ACLX vs IPM — Head-to-Head

Bigger by revenue
ACLX
ACLX
1.3× larger
ACLX
$8.1M
$6.1M
IPM
Growing faster (revenue YoY)
IPM
IPM
+2170.9% gap
IPM
2091.6%
-79.3%
ACLX
Faster 2-yr revenue CAGR
IPM
IPM
Annualised
IPM
54.7%
-24.6%
ACLX

Income Statement — Q1 FY2025 vs Q4 FY2025

Metric
ACLX
ACLX
IPM
IPM
Revenue
$8.1M
$6.1M
Net Profit
$-62.3M
Gross Margin
53.1%
Operating Margin
-847.6%
-13.4%
Net Margin
-766.0%
Revenue YoY
-79.3%
2091.6%
Net Profit YoY
-765.1%
EPS (diluted)
$-1.13
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACLX
ACLX
IPM
IPM
Q4 25
$6.1M
Q3 25
$6.2M
Q2 25
$5.7M
Q1 25
$8.1M
$5.5M
Q4 24
$15.3M
Q3 24
$26.0M
Q2 24
$27.4M
Q1 24
$39.3M
Net Profit
ACLX
ACLX
IPM
IPM
Q4 25
Q3 25
$-1.1M
Q2 25
$-1.1M
Q1 25
$-62.3M
$808.5K
Q4 24
$-47.1M
Q3 24
$-25.9M
Q2 24
$-27.2M
Q1 24
$-7.2M
Gross Margin
ACLX
ACLX
IPM
IPM
Q4 25
53.1%
Q3 25
50.7%
Q2 25
50.1%
Q1 25
55.3%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
ACLX
ACLX
IPM
IPM
Q4 25
-13.4%
Q3 25
-23.0%
Q2 25
-19.7%
Q1 25
-847.6%
-24.2%
Q4 24
-348.2%
Q3 24
-129.1%
Q2 24
-127.8%
Q1 24
-40.3%
Net Margin
ACLX
ACLX
IPM
IPM
Q4 25
Q3 25
-17.4%
Q2 25
-18.3%
Q1 25
-766.0%
14.7%
Q4 24
-308.4%
Q3 24
-99.4%
Q2 24
-99.3%
Q1 24
-18.3%
EPS (diluted)
ACLX
ACLX
IPM
IPM
Q4 25
$-0.05
Q3 25
$-0.08
Q2 25
$-0.08
Q1 25
$-1.13
$0.06
Q4 24
$-0.87
Q3 24
$-0.48
Q2 24
$-0.51
Q1 24
$-0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACLX
ACLX
IPM
IPM
Cash + ST InvestmentsLiquidity on hand
$543.3M
$5.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$416.9M
$18.2M
Total Assets
$648.1M
$26.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACLX
ACLX
IPM
IPM
Q4 25
$5.6M
Q3 25
$7.3M
Q2 25
$7.3M
Q1 25
$543.3M
$9.7M
Q4 24
$587.4M
Q3 24
$574.3M
Q2 24
$516.7M
Q1 24
$573.9M
Stockholders' Equity
ACLX
ACLX
IPM
IPM
Q4 25
$18.2M
Q3 25
$18.8M
Q2 25
$19.9M
Q1 25
$416.9M
$21.1M
Q4 24
$454.8M
Q3 24
$483.0M
Q2 24
$487.2M
Q1 24
$496.6M
Total Assets
ACLX
ACLX
IPM
IPM
Q4 25
$26.0M
Q3 25
$27.2M
Q2 25
$29.8M
Q1 25
$648.1M
$31.1M
Q4 24
$711.3M
Q3 24
$764.9M
Q2 24
$734.3M
Q1 24
$779.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACLX
ACLX
IPM
IPM
Operating Cash FlowLast quarter
$-63.1M
$87.6K
Free Cash FlowOCF − Capex
$-63.9M
FCF MarginFCF / Revenue
-786.4%
Capex IntensityCapex / Revenue
9.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-122.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACLX
ACLX
IPM
IPM
Q4 25
$87.6K
Q3 25
$133.0K
Q2 25
$-888.7K
Q1 25
$-63.1M
$1.7M
Q4 24
$-46.0M
Q3 24
$30.7M
Q2 24
$-36.2M
Q1 24
$-31.9M
Free Cash Flow
ACLX
ACLX
IPM
IPM
Q4 25
Q3 25
Q2 25
Q1 25
$-63.9M
Q4 24
$-47.5M
Q3 24
$28.4M
Q2 24
$-39.5M
Q1 24
$-38.3M
FCF Margin
ACLX
ACLX
IPM
IPM
Q4 25
Q3 25
Q2 25
Q1 25
-786.4%
Q4 24
-311.3%
Q3 24
109.2%
Q2 24
-144.1%
Q1 24
-97.7%
Capex Intensity
ACLX
ACLX
IPM
IPM
Q4 25
Q3 25
0.0%
Q2 25
Q1 25
9.6%
Q4 24
9.8%
Q3 24
8.8%
Q2 24
11.7%
Q1 24
16.4%
Cash Conversion
ACLX
ACLX
IPM
IPM
Q4 25
Q3 25
Q2 25
Q1 25
2.16×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACLX
ACLX

Segment breakdown not available.

IPM
IPM

Procurement Revenue$5.4M88%
Other$743.9K12%

Related Comparisons